Clinical Trial Update: A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for TQB3909 tablets in advanced breast cancer across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• TQB3909

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN